Close

BIO To File Court Papers In Support Of Plant Patents

The Biotechnology Industry Organization (BIO) said today it will support Pioneer HiBred International Inc. in efforts to protect the validity of patents for genetically modified plants.

Biotech President Sees More Medical Breakthroughs And Good Investment Opportunities Ahead

NEW YORK, N.Y., (February 24, 1999) -- Twenty-one new biotechnology drugs, vaccines and new indications for existing drugs were approved by the Food and Drug Administration (FDA) in 1998.

...

BIO Responds To Bt Lawsuit

...

Price Controls Promise Only To Undermine Biotech Drug Development

...

Women's Health Issues Explored At BIO CEO & Investor Conference

...

52 Companies To Make Presentations At BIO's Annual CEO & Investor Conference

...

BIO Statement on Iceland Genetic Data

...

Canada's Decision on BST Counters FDA, WHO, AMA Views

...

BIO Statement Regarding Commercial Development of Pluripotent Stem Cells

To the Subcommittee on Labor, Health and Human Services, Education of the Senate Appropriations Committee

BIO Urges President's Bioethics Advisory Panel To Consider Issues Raised By Stem Cell Research

Carl B Feldbaum, president of  BIO, today issued the following statement on the need for national discussion based on the ethical implications of recent research breakthroughs involving primordial human stem cells...